The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy of subsequent treatments after disease progression on CDK4/6 inhibitors therapy in patients with hormone receptor-positive metastatic breast cancer: A Kaplan-Meier derived individual-patient data meta-analysis.
 
Lis Victoria Ravani
No Relationships to Disclose
 
Pedro Calomeni
No Relationships to Disclose
 
Maysa Vilbert
No Relationships to Disclose
 
Thiago Madeira
No Relationships to Disclose
 
Ming Wang
No Relationships to Disclose
 
Daxuan Deng
No Relationships to Disclose
 
Laura Testa
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Daiichi Sankyo/Astra Zeneca; Daiichi Sankyo/Astra Zeneca; Lilly; Lilly; MSD Oncology; MSD Oncology; MSD/AstraZeneca; Novartis; Pfizer
Speakers' Bureau - Daiichi Sankyo/Astra Zeneca; Lilly; MSD Oncology; Novartis; Pfizer
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Gilead Sciences; Roche
 
Katherine Clifton
Employment - Zing Health (I)
Stock and Other Ownership Interests - Centene (I); WellCare (I)
Consulting or Advisory Role - bioTheranostics; Pfizer
 
Seth Andrew Wander
Consulting or Advisory Role - AstraZeneca; Biovica; Foundation Medicine; Hologic; Lilly; Novartis; Pfizer; Puma Biotechnology; Veracyte
Speakers' Bureau - 2nd.MD; Guardant Health; Lilly; Novartis
Research Funding - Genentech; Lilly; Nuvation Bio; Pfizer; Regor Therapeutics; Sermonix Pharmaceuticals
 
Maryam B. Lustberg
Honoraria - Novartis
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; Lilly; Novartis; Osmol Therapeutics; Pfizer; Seagen
Speakers' Bureau - Lilly
Other Relationship - Cynosure/Hologic